D. Le Grand

Development of isoform selective PI3-kinase inhibitors as pharmacological tools for elucidating the PI3K pathway.

P. Finan, B. Cuenoud, C. Leblanc, 2012, Bioorganic & medicinal chemistry letters.

Development of autotaxin inhibitors: A series of zinc binding triazoles.

M. Dowling, M. Faller, E. Hardaker, 2018, Bioorganic & medicinal chemistry letters.

Deazaflavin Inhibitors of TDP2 with Cellular Activity Can Affect Etoposide Influx and/or Efflux.

K. Caldecott, E. Komulainen, Lewis E. Pennicott, 2019, ACS chemical biology.

The discovery of orally available thrombin inhibitors: studies towards the optimisation of CGH1668.

D. Janus, K. Menear, David J. Farr, 1998, Bioorganic & medicinal chemistry letters.

Studies towards the identification of potent, selective and bioavailable thrombin inhibitors.

D. Janus, K. Menear, D. Bentley, 1999, Bioorganic & medicinal chemistry letters.

A first generation inhibitor of human Greatwall kinase, enabled by structural and functional characterisation of a minimal kinase domain construct

Frances M. G. Pearl, L. Pearl, F. Pearl, 2016, Oncotarget.

The discovery of orally available thrombin inhibitors: optimisation of the P1 pharmacophore.

B. Wathey, D. Janus, K. Menear, 1999, Bioorganic & medicinal chemistry letters.